2015
DOI: 10.1007/s11738-015-2008-3
|View full text |Cite
|
Sign up to set email alerts
|

Silymarin: an insight to its formulation and analytical prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 115 publications
0
7
0
2
Order By: Relevance
“…Worth mentioning here is the fact that silymarin has very poor oral bioavailability, acid instability, and poor solubility [40]. Hence, to be administered orally, it should be formulated in novel drug delivery systems such as porous silica nanoparticles, phospholipid complexes, or liposomes [40]. In the current study, i. p. route of administration was selected to overcome such limitations.…”
Section: Discussionmentioning
confidence: 99%
“…Worth mentioning here is the fact that silymarin has very poor oral bioavailability, acid instability, and poor solubility [40]. Hence, to be administered orally, it should be formulated in novel drug delivery systems such as porous silica nanoparticles, phospholipid complexes, or liposomes [40]. In the current study, i. p. route of administration was selected to overcome such limitations.…”
Section: Discussionmentioning
confidence: 99%
“…The silymarin powder was weighed 200 mg and added 0.5% Na-CMC gradually while crushed until it homogenous. The suspension was added with Na-CMC suspension of 0.5% (Ahmad et al 2015).…”
Section: Preparation Of Silymarin Suspensionmentioning
confidence: 99%
“…The four major causes of limited silymarin bioavailability are extensive phase II metabolism, low permeability across intestinal epithelial cells, low aqueous solubility, and rapid excretion in bile and urine. These factors necessitate the incorporation of silymarin into a form that can augment its bioavailability [5].…”
Section: Introductionmentioning
confidence: 99%